Heart Disease News and Research

Latest Heart Disease News and Research

CardioFocus introduces HeartLight Endoscopic Ablation System for AF in the Netherlands

CardioFocus, Inc., developer of the HeartLight Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announces its technology is now available in the Netherlands. Physicians at Isala Klinieken in Zwolle were the first in the country to incorporate visually guided ablation into their regular therapeutic practice and have successfully treated several patients.

26 Mar 2012

Raisins may help lower blood pressure

If you have slightly higher than normal blood pressure - known as prehypertension - consider eating a handful of raisins. New data suggest that, among individuals with mild increases in blood pressure, the routine consumption of raisins (three times a day) may significantly lower blood pressure, especially when compared to eating other common snacks, according to research presented today at the American College of Cardiology's 61st Annual Scientific Session.

26 Mar 2012

Stem cells from own bone marrow improve heart function

A research network led by a Mayo Clinic physician found that stem cells derived from heart failure patients' own bone marrow and injected into their hearts improved the function of the left ventricle, the heart's pumping chamber. Researchers also found that certain types of the stem cells were associated with the largest improvement and warrant further study.

26 Mar 2012

CCTA identifies more patients with coronary artery disease

Coronary CT angiography (CCTA) scans allow doctors to determine safely and more quickly which patients at low-to intermediate-risk for a heart attack can be discharged from hospital emergency departments (EDs) than traditional methods, according to the results of a large, multicenter American College of Radiology Imaging Network (ACRIN) trial published online today in the New England Journal of Medicine.

26 Mar 2012

Cheney surgery sparks discussion of age and heart transplants

Over the weekend, former Vice President Dick Cheney, who is 71, received a new heart after he had waited 20 months.

26 Mar 2012

Synthetic pasta-like objects are major chemistry advances for regenerative medicine

Medicine's recipe for keeping older people active and functioning in their homes and workplaces - and healing younger people injured in catastrophic accidents - may include "noodle gels" and other lab-made invisible filaments that resemble uncooked spaghetti with nanoscale dimensions, a scientist said here today at the 243rd National Meeting & Exposition of the American Chemical Society (ACS).

26 Mar 2012

Theracurmin shows positive impact on human diastolic functions

The research group led by Dr. Koji Hasegawa, Director of the Translational Research Division at the National Hospital Organization Kyoto Medical Center and Dr. Tatsuya Morimoto, Professor at the Molecular Medicine School of Pharmaceutical Sciences, University of Shizuoka, announced today based on the recent human clinical trials, that Theracurmin has continuously shown positive impact on human diastolic functions.

26 Mar 2012

Population-wide community and clinical prevention program reduces cardiovascular risk profile

A population-wide community and clinical prevention program involving 10,000 adults meaningfully reduced the cardiovascular (CV) risk profile among a substantial portion of the population as indicated by those participating in screenings. Findings also indicate the level of improvements differ by gender for specific cardiovascular risk factors.

26 Mar 2012

Promising results from Esperion ETC-1002 Phase 2 clinical trial for dyslipidemia

Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced positive results from a Phase 2 clinical trial for ETC-1002.

26 Mar 2012

PCI may be an excellent option for STEMI patients 90 years and older

Selected patients 90 years and older who experience an acute heart attack, or ST-elevation myocardial infarction (STEMI), have reasonable outcomes with coronary stenting, and should be considered for reperfusion therapy, based on a scientific poster being presented at the 61st annual American College of Cardiology (ACC) scientific session.

26 Mar 2012

Multifaceted intervention improves use of evidence-based medicines

Among patients with acute coronary syndromes (such as heart attack or unstable angina) treated at public hospitals in Brazil, implementation of a multifaceted intervention that included educational materials, checklists and reminders resulted in improvement in the use of evidence-based medicines during the first 24 hours of hospitalization, according to a study appearing in JAMA.

26 Mar 2012

Toshiba highlights Aquilion ONE and CT Myocardial Analysis at ACC annual meet

As the only CT system with a detector wide enough to capture the entire heart in a single rotation, Toshiba America Medical Systems, Inc.'s Aquilion ONE dynamic volume CT system, combined with Vital Images' CT Myocardial Analysis software, provides clinicians with images of both cardiac anatomy and function for cardiac ischemia diagnoses.

26 Mar 2012

Blockages in right coronary artery are most common places for coronary dissection

Researchers from Thomas Jefferson University Hospital discovered that blockages in the right coronary artery and those in bending areas of the coronary artery are the most common places for coronary dissection, a tear in the artery that can occur during balloon angioplasty of the coronary arteries.

26 Mar 2012

Toshiba's Infinix-i cardiovascular X-ray system highlighted at ACC 2012

The design of Toshiba's Infinix-i cardiovascular X-ray system improves patient access in the cath lab during transradial and transcatheter aortic-valve replacement (TAVR) intervention, resulting in better patient care and outcomes.

26 Mar 2012

First Edition: March 26, 2012

Today marks the beginning of the Supreme Court's three days of oral arguments regarding the health law. Headlines break down the key points of those arguments, as well as the political and historical context in which they will be advanced.

26 Mar 2012

Results from Merck's vorapaxar study on cardiovascular events

Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.

26 Mar 2012

Minimally invasive endovascular treatment for CCSVI is safe in patients with MS

Researchers who investigated the connection between chronic cerebrospinal venous insufficiency (a reported condition characterized as a blockage in the veins that drain blood from the brain and spinal cord and returns it to the heart) and multiple sclerosis indicate that a minimally invasive endovascular treatment for CCSVI, is safe and may produce "significant," short-term improvement in physical- and mental health-related quality of life in individuals with MS.

26 Mar 2012

ETC-1002 drug reduces LDL cholesterol levels in hypercholesterolemic patients

Early data suggest ETC-1002, a drug that regulates lipid and carbohydrate metabolism, had a significant impact on cholesterol levels and improved factors believed to contribute to cardio-metabolic diseases, say researchers from the Methodist DeBakey Heart & Vascular Center, the Baylor College of Medicine, and Esperion Therapeutics, Inc., who are presenting their work at the 2012 American College of Cardiology Scientific Session in Chicago.

26 Mar 2012

Largest study to date to look at BMC therapy in patients with heart failure

Use of a patient's bone marrow cells for treating chronic ischemic heart failure did not result in improvement on most measures of heart function, according to a study appearing in JAMA. The study is being published early online to coincide with its presentation at the American College of Cardiology's annual scientific sessions.

26 Mar 2012

Periodontal treatment may decrease medical care costs for people with diabetes

Medical costs are lower for people with diabetes who receive treatment for gum disease, according to a study presented today to the American Association for Dental Research by Dr. Marjorie Jeffcoat of the University of Pennsylvania.

26 Mar 2012